Titre : Diagnostic préimplantatoire

Diagnostic préimplantatoire : Questions médicales fréquentes

Termes MeSH sélectionnés :

Immunization Programs
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Diagnostic préimplantatoire : Questions médicales les plus fréquentes", "headline": "Diagnostic préimplantatoire : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Diagnostic préimplantatoire : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-21", "dateModified": "2025-04-17", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Diagnostic préimplantatoire" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Techniques de diagnostic gynécologique et obstétrique", "url": "https://questionsmedicales.fr/mesh/D003944", "about": { "@type": "MedicalCondition", "name": "Techniques de diagnostic gynécologique et obstétrique", "code": { "@type": "MedicalCode", "code": "D003944", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E01.370.378" } } }, "about": { "@type": "MedicalCondition", "name": "Diagnostic préimplantatoire", "alternateName": "Preimplantation Diagnosis", "code": { "@type": "MedicalCode", "code": "D019836", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Xueqing Wu", "url": "https://questionsmedicales.fr/author/Xueqing%20Wu", "affiliation": { "@type": "Organization", "name": "Center of Reproductive Medicine, Children's Hospital of Shanxi and Women Health Center of Shanxi, Taiyuan, Shanxi, 030013, PR China. xueqingwu416@126.com." } }, { "@type": "Person", "name": "Chi-Fang Lin", "url": "https://questionsmedicales.fr/author/Chi-Fang%20Lin", "affiliation": { "@type": "Organization", "name": "Department of Genomic Medicine and Center for Medical Genetics, Changhua Christian Hospital, Changhua 50046, Taiwan." } }, { "@type": "Person", "name": "Gwo-Chin Ma", "url": "https://questionsmedicales.fr/author/Gwo-Chin%20Ma", "affiliation": { "@type": "Organization", "name": "Department of Genomic Medicine and Center for Medical Genetics, Changhua Christian Hospital, Changhua 50046, Taiwan." } }, { "@type": "Person", "name": "Shun-Ping Chang", "url": "https://questionsmedicales.fr/author/Shun-Ping%20Chang", "affiliation": { "@type": "Organization", "name": "Department of Genomic Medicine and Center for Medical Genetics, Changhua Christian Hospital, Changhua 50046, Taiwan." } }, { "@type": "Person", "name": "Ming Chen", "url": "https://questionsmedicales.fr/author/Ming%20Chen", "affiliation": { "@type": "Organization", "name": "Department of Genomic Medicine and Center for Medical Genetics, Changhua Christian Hospital, Changhua 50046, Taiwan." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Impact of the national hepatitis B immunization program in China: a modeling study.", "datePublished": "2022-10-11", "url": "https://questionsmedicales.fr/article/36221140", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s40249-022-01032-5" } }, { "@type": "ScholarlyArticle", "name": "Parental knowledge on the respiratory syncytial virus before the nirsevimab immunization program: Attitudes toward immunization in an autonomous community of Spain.", "datePublished": "2024-06-10", "url": "https://questionsmedicales.fr/article/38857859", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/21645515.2024.2357439" } }, { "@type": "ScholarlyArticle", "name": "Cost-benefit analysis of rotavirus vaccine included in the national immunization program in China.", "datePublished": "2022-12-08", "url": "https://questionsmedicales.fr/article/36503856", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.vaccine.2022.11.074" } }, { "@type": "ScholarlyArticle", "name": "Investigation of non-National Immunization Program vaccination intentions in rural areas of China.", "datePublished": "2023-08-04", "url": "https://questionsmedicales.fr/article/37542236", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12889-023-16390-4" } }, { "@type": "ScholarlyArticle", "name": "Vaccination compliance of selected childhood immunization programs and the socio-determinant factors in Nigeria.", "datePublished": "2023-10-31", "url": "https://questionsmedicales.fr/article/37956381", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3855/jidc.17886" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Diagnostic", "item": "https://questionsmedicales.fr/mesh/D003933" }, { "@type": "ListItem", "position": 3, "name": "Techniques et procédures diagnostiques", "item": "https://questionsmedicales.fr/mesh/D019937" }, { "@type": "ListItem", "position": 4, "name": "Techniques de diagnostic gynécologique et obstétrique", "item": "https://questionsmedicales.fr/mesh/D003944" }, { "@type": "ListItem", "position": 5, "name": "Diagnostic préimplantatoire", "item": "https://questionsmedicales.fr/mesh/D019836" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Diagnostic préimplantatoire - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Diagnostic préimplantatoire", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-02", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Diagnostic préimplantatoire", "description": "Qu'est-ce que le diagnostic préimplantatoire ?\nComment se déroule le diagnostic préimplantatoire ?\nQuels types de maladies peuvent être détectées ?\nQui peut bénéficier du diagnostic préimplantatoire ?\nQuelle est la précision du diagnostic préimplantatoire ?", "url": "https://questionsmedicales.fr/mesh/D019836?mesh_terms=Immunization+Programs&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Diagnostic préimplantatoire", "description": "Quels symptômes indiquent un besoin de diagnostic préimplantatoire ?\nLes symptômes de maladies génétiques sont-ils visibles ?\nComment les maladies génétiques se manifestent-elles ?\nLes symptômes sont-ils identiques chez tous les patients ?\nPeut-on prédire les symptômes futurs d'un enfant ?", "url": "https://questionsmedicales.fr/mesh/D019836?mesh_terms=Immunization+Programs&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Diagnostic préimplantatoire", "description": "Comment prévenir les maladies génétiques ?\nLe mode de vie influence-t-il les maladies génétiques ?\nLes tests génétiques sont-ils recommandés avant la grossesse ?\nLes vaccinations peuvent-elles prévenir des maladies génétiques ?\nLe suivi médical est-il important pour la prévention ?", "url": "https://questionsmedicales.fr/mesh/D019836?mesh_terms=Immunization+Programs&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Diagnostic préimplantatoire", "description": "Quel traitement suit le diagnostic préimplantatoire ?\nLe diagnostic préimplantatoire remplace-t-il d'autres traitements ?\nY a-t-il des traitements associés au diagnostic ?\nQuels sont les risques des traitements associés ?\nLe diagnostic préimplantatoire est-il remboursé ?", "url": "https://questionsmedicales.fr/mesh/D019836?mesh_terms=Immunization+Programs&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Diagnostic préimplantatoire", "description": "Quelles complications peuvent survenir lors du diagnostic ?\nLe diagnostic préimplantatoire peut-il échouer ?\nLes complications affectent-elles la grossesse ?\nY a-t-il des risques psychologiques associés ?\nComment gérer les complications éventuelles ?", "url": "https://questionsmedicales.fr/mesh/D019836?mesh_terms=Immunization+Programs&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Diagnostic préimplantatoire", "description": "Quels sont les facteurs de risque pour les maladies génétiques ?\nL'environnement influence-t-il les maladies génétiques ?\nLes maladies génétiques sont-elles plus fréquentes chez certaines ethnies ?\nLe mode de vie peut-il réduire les risques ?\nLes tests de dépistage sont-ils utiles pour évaluer les risques ?", "url": "https://questionsmedicales.fr/mesh/D019836?mesh_terms=Immunization+Programs&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Qu'est-ce que le diagnostic préimplantatoire ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "C'est une méthode pour analyser les embryons avant leur implantation afin de détecter des anomalies génétiques." } }, { "@type": "Question", "name": "Comment se déroule le diagnostic préimplantatoire ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Il implique la biopsie d'un embryon suivi d'analyses génétiques pour identifier des maladies héréditaires." } }, { "@type": "Question", "name": "Quels types de maladies peuvent être détectées ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "On peut détecter des maladies monogéniques, des anomalies chromosomiques et des troubles héréditaires." } }, { "@type": "Question", "name": "Qui peut bénéficier du diagnostic préimplantatoire ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les couples à risque de transmettre des maladies génétiques ou ayant des antécédents de fausses couches." } }, { "@type": "Question", "name": "Quelle est la précision du diagnostic préimplantatoire ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "La précision est élevée, mais il existe un risque de faux positifs ou négatifs dans certains cas." } }, { "@type": "Question", "name": "Quels symptômes indiquent un besoin de diagnostic préimplantatoire ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des antécédents familiaux de maladies génétiques ou des échecs répétés de grossesse peuvent alerter." } }, { "@type": "Question", "name": "Les symptômes de maladies génétiques sont-ils visibles ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Pas toujours, certaines maladies peuvent ne pas se manifester avant plusieurs années." } }, { "@type": "Question", "name": "Comment les maladies génétiques se manifestent-elles ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent se manifester par des troubles physiques, cognitifs ou des malformations congénitales." } }, { "@type": "Question", "name": "Les symptômes sont-ils identiques chez tous les patients ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Non, les symptômes varient selon la maladie et la génétique individuelle de chaque patient." } }, { "@type": "Question", "name": "Peut-on prédire les symptômes futurs d'un enfant ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic préimplantatoire peut aider à prédire certains risques, mais pas tous." } }, { "@type": "Question", "name": "Comment prévenir les maladies génétiques ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Le conseil génétique et le diagnostic préimplantatoire sont des outils clés pour la prévention." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il les maladies génétiques ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Le mode de vie n'influence pas les maladies génétiques, mais peut affecter la santé globale." } }, { "@type": "Question", "name": "Les tests génétiques sont-ils recommandés avant la grossesse ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les tests peuvent aider à identifier les risques génétiques avant de concevoir." } }, { "@type": "Question", "name": "Les vaccinations peuvent-elles prévenir des maladies génétiques ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Non, les vaccinations ne préviennent pas les maladies génétiques, mais elles protègent contre les infections." } }, { "@type": "Question", "name": "Le suivi médical est-il important pour la prévention ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un suivi médical régulier aide à identifier les risques et à prendre des mesures préventives." } }, { "@type": "Question", "name": "Quel traitement suit le diagnostic préimplantatoire ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les embryons sains sont sélectionnés pour implantation lors d'une fécondation in vitro." } }, { "@type": "Question", "name": "Le diagnostic préimplantatoire remplace-t-il d'autres traitements ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Non, il est complémentaire à d'autres traitements de fertilité et ne les remplace pas." } }, { "@type": "Question", "name": "Y a-t-il des traitements associés au diagnostic ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des traitements hormonaux peuvent être nécessaires pour préparer l'utérus à l'implantation." } }, { "@type": "Question", "name": "Quels sont les risques des traitements associés ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les risques incluent des effets secondaires des médicaments et des complications lors de la biopsie." } }, { "@type": "Question", "name": "Le diagnostic préimplantatoire est-il remboursé ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Le remboursement dépend des pays et des politiques de santé, souvent partiel ou conditionnel." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir lors du diagnostic ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications peuvent inclure des saignements, des infections ou des dommages embryonnaires." } }, { "@type": "Question", "name": "Le diagnostic préimplantatoire peut-il échouer ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il existe un risque d'échec dans la détection des anomalies ou d'implantation." } }, { "@type": "Question", "name": "Les complications affectent-elles la grossesse ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent affecter la grossesse, mais beaucoup de femmes ont des grossesses saines." } }, { "@type": "Question", "name": "Y a-t-il des risques psychologiques associés ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress et l'anxiété liés aux résultats peuvent affecter le bien-être psychologique des couples." } }, { "@type": "Question", "name": "Comment gérer les complications éventuelles ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi médical et un soutien psychologique sont essentiels pour gérer les complications." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les maladies génétiques ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents familiaux, l'âge avancé des parents et certaines ethnies augmentent les risques." } }, { "@type": "Question", "name": "L'environnement influence-t-il les maladies génétiques ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "L'environnement a peu d'impact sur les maladies génétiques, qui sont principalement héréditaires." } }, { "@type": "Question", "name": "Les maladies génétiques sont-elles plus fréquentes chez certaines ethnies ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines ethnies ont des prédispositions à des maladies génétiques spécifiques." } }, { "@type": "Question", "name": "Le mode de vie peut-il réduire les risques ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sain peut améliorer la santé générale, mais ne réduit pas les risques génétiques." } }, { "@type": "Question", "name": "Les tests de dépistage sont-ils utiles pour évaluer les risques ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les tests de dépistage génétique aident à évaluer les risques de transmission de maladies." } } ] } ] }

Sources (10000 au total)

Impact of the national hepatitis B immunization program in China: a modeling study.

Elimination of hepatitis B virus (HBV) is a striking challenge for countries with high or moderate disease burden. Therefore, using China as a practical case to share experiences for similar countries... We constructed an expanded Susceptible-Exposed-Infectious-Recovered (SEIR) model and decision tree-Markov model to estimate the epidemic of HBV in China, assess the feasibility of 2030 Elimination Goa... Between 1990 and 2020, the number of chronic HBV infections decreased by 33.9%. The current status quo would lead to 55.73 million infections (3.95% prevalence) in 2030, compared to 90.63 million (6.4... Our findings proved the HBV vaccination has demonstrated a substantial positive impact on controlling the epidemic of HBV in terms of effectiveness and economy after about 30 years of implementation o...

Parental knowledge on the respiratory syncytial virus before the nirsevimab immunization program: Attitudes toward immunization in an autonomous community of Spain.

Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infections in young children and associated with most bronchiolitis- and pneumonia-related hospitalizations. A new pre...

Cost-benefit analysis of rotavirus vaccine included in the national immunization program in China.

Globally, rotavirus is a leading cause of severe acute gastroenteritis among children aged under 5 years and has a significant economic cost. Currently, rotavirus vaccines are only included in the pri... A decision tree Markov model was constructed to evaluate the cost-benefit of universal immunization with three doses of rotavirus vaccine for a 2019 birth cohort of Chinese children. Costs of the univ... For the 2019 birth cohort of Chinese infants, inclusion of RotaTeq in NIP was estimated to prevent 5,677,911 cases of rotavirus infection, with net savings of $1.1 billion in total societal costs. A c... Introducing rotavirus vaccine into the China NIP would have significant costs from a societal perspective at the current private market price....

Investigation of non-National Immunization Program vaccination intentions in rural areas of China.

China's current immunization program was revised in 2007. Some common childhood vaccines such as those for influenza, pediatric pneumonia, Haemophilus influenzae, varicella, and rotavirus have not bee... A qualitative method of in-depth interviews were conducted for this study. We interviewed 30 rural parents in a central Chinese village to investigate their awareness of non-NIP vaccines and their vac... This study summarized the individual and social level factors influencing the non-NIP vaccination intention of rural parents. The individual level factors include four themes: perceived severity with ... Based on these influencing factors, this study constructs a structural model for non-NIP vaccination decision-making process in rural areas of China. The results play a guiding role in directing atten...

Vaccination compliance of selected childhood immunization programs and the socio-determinant factors in Nigeria.

Adherence to full vaccination is important in preventing childhood diseases. The aim of this study was to evaluate the level of compliance to full vaccination and identify the socio-cultural factors a... The socioeconomic variables associated with each of the four binary dependent variables of whether or not a child is fully vaccinated against tetanus, BCG, measles, and pentavalent were determined usi... While compliance to full tetanus and BCG vaccinations was > 60% at the national level, less than 50% and 10% full vaccination compliance were recorded for pentavalent and measles vaccinations, respect... The socio-cultural factors associated with achieving full vaccination coverage in Nigeria in this study should drive the implementation of policies that will be best suited to each geopolitical zone o...

Economic assessment of incorporating the hexavalent vaccine as part of the National Immunization Program of Peru.

This study aimed to estimate the economic impact of replacing the current Peruvian primary immunization scheme for infants under 1 year old with an alternative scheme with similar efficacy, based on a... A cost-minimization analysis compared the costs associated with vaccine administration, adverse reactions medical treatment, logistical activities, and indirect social costs associated with time spent... Incorporating the hexavalent vaccine would result in a 15.5% net increase in healthcare budget expenditure ($48,281,706 vs $55,744,653). Vaccination costs would increase by 54.1%, whereas logistical a... Despite of the significant reduction of logistical and adverse reaction costs, including the hexavalent vaccine into the National Immunization Program of Peru in place of the current vaccination schem...

Resilience learning from the COVID-19 pandemic and its relevance for routine immunization programs.

The COVID-19 pandemic represents a threat that has posed a challenge to public health response and threatens immunization programs globally. Despite recommendations to continue routine immunization se... We conducted a systematic literature review to identify studies globally that described how indicators of health system resilience, defined using the Resilient Health System Framework, enabled routine... Our study demonstrates the use of tools that contributed to immunization program resilience during the COVID-19 pandemic in all geographic regions and for countries with different income levels. These...